Sentiment-Signal
14,7
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Unternehmen & Branche
| Name | TRUPANION, INC. |
|---|---|
| Ticker | TRUP |
| CIK | 0001371285 |
| Boerse | US |
| Sektor | Financial Services |
| Industrie | Insurance - Specialty |
| SIC | 6324 · Hospital & Medical Service Plans |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,09 Mrd. USD |
| Beta | 1,66 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,439,305,000 | 0.45 | 915,044,000 | 383,936,000 | |
| 2025-09-30 | 10-Q | 366,920,000 | 0.13 | 880,173,000 | 368,562,000 | |
| 2025-06-30 | 10-Q | 353,557,000 | 0.22 | 847,789,000 | 355,454,000 | |
| 2025-03-31 | 10-Q | 341,975,000 | -0.03 | 837,162,000 | 333,673,000 | |
| 2024-12-31 | 10-K | 1,285,684,000 | -0.23 | 806,853,000 | 323,268,000 | |
| 2024-09-30 | 10-Q | 327,456,000 | 0.03 | 816,118,000 | 320,175,000 | |
| 2024-06-30 | 10-Q | 314,800,000 | -0.14 | 795,946,000 | 305,848,000 | |
| 2024-03-31 | 10-Q | 306,121,000 | -0.16 | 789,460,000 | 303,371,000 | |
| 2023-12-31 | 10-K | 1,108,605,000 | -1.08 | 782,948,000 | 303,722,000 | |
| 2023-09-30 | 10-Q | 285,853,000 | -0.10 | 772,034,000 | 289,465,000 | |
| 2023-06-30 | 10-Q | 270,566,000 | -0.33 | 730,191,000 | 288,758,000 | |
| 2023-03-31 | 10-Q | 256,329,000 | -0.60 | 717,914,000 | 294,809,000 | |
| 2022-12-31 | 10-K | 905,179,000 | -1.10 | 671,627,000 | 305,297,000 | |
| 2022-09-30 | 10-Q | 233,760,000 | -0.32 | 647,896,000 | 305,738,000 | |
| 2022-06-30 | 10-Q | 219,411,000 | -0.33 | 635,170,000 | 314,754,000 | |
| 2022-03-31 | 10-Q | 205,999,000 | -0.22 | 634,611,000 | 328,533,000 | |
| 2021-12-31 | 10-K | 698,991,000 | -0.89 | 562,582,000 | 332,200,000 | |
| 2021-09-30 | 10-Q | 181,667,000 | -0.17 | 550,710,000 | 331,973,000 | |
| 2021-06-30 | 10-Q | 168,260,000 | -0.23 | 531,966,000 | 334,205,000 | |
| 2021-03-31 | 10-Q | 154,685,000 | -0.31 | 513,698,000 | 336,077,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -430 | 25.47 | -10,952.10 | -5,4% | |
| 2026-03-04 | DREYER EMILY | Officer, Chief Revenue Officer | Open Market Sale | -7,792 | 28.15 | -219,319.87 | -108,7% | |
| 2026-02-27 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -5,283 | 26.52 | -140,080.33 | -69,4% | |
| 2026-02-27 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -2,837 | 26.46 | -75,075.25 | -37,2% | |
| 2026-02-25 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -4,645 | 25.61 | -118,958.45 | -58,9% | |
| 2026-02-25 | WEINRAUCH STEVE | Officer, EVP, North Am & Vet Strategy | Open Market Sale | -85 | 26.70 | -2,269.50 | -1,1% | |
| 2026-01-28 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -430 | 31.67 | -13,618.10 | -6,7% | |
| 2025-12-29 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -430 | 37.55 | -16,146.50 | -8,0% | |
| 2025-12-19 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -8,000 | 37.88 | -303,004.80 | -150,1% | |
| 2025-12-19 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -1,605 | 37.91 | -60,844.75 | -30,1% | |
| 2025-11-28 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -6,383 | 34.82 | -222,282.87 | -110,1% | |
| 2025-11-26 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -6,202 | 35.45 | -219,836.71 | -108,9% | |
| 2025-11-25 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -8,000 | 35.31 | -282,480.00 | -139,9% | |
| 2025-11-25 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -1,803 | 35.31 | -63,663.93 | -31,5% | |
| 2025-10-27 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -6,000 | 43.72 | -262,339.80 | -130,0% | |
| 2025-10-27 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -2,884 | 43.74 | -126,153.08 | -62,5% | |
| 2025-09-25 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -2,961 | 41.88 | -124,002.53 | -61,4% | |
| 2025-09-25 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -2,961 | 41.88 | -124,002.53 | -61,4% | |
| 2025-09-25 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -6,000 | 41.89 | -251,315.40 | -124,5% | |
| 2025-09-04 | RAWLINGS DARRYL | Director | Open Market Sale | -30,369 | 44.70 | -1,357,500.37 | -672,5% | |
| 2025-09-03 | RAWLINGS DARRYL | Director | Open Market Sale | -19,631 | 44.79 | -879,225.38 | -435,6% | |
| 2025-09-02 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -6,451 | 45.15 | -291,293.61 | -144,3% | |
| 2025-08-26 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -2,800 | 45.56 | -127,574.16 | -63,2% | |
| 2025-06-06 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -200 | 48.57 | -9,714.00 | -4,8% | |
| 2025-06-02 | MCGIBNEY BRENNA | Officer, Chief Administration Officer | Open Market Sale | -2,390 | 45.17 | -107,956.30 | -53,5% | |
| 2025-05-29 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -2,534 | 48.31 | -122,405.63 | -60,6% | |
| 2025-05-29 | GALLAGHER JOHN R | Officer, Chief Operating Officer | Open Market Sale | -4,000 | 47.90 | -191,600.00 | -94,9% | |
| 2025-05-27 | Qureshi Fawwad | Officer, Chief Financial Officer | Open Market Sale | -828 | 45.53 | -37,698.84 | -18,7% | |
| 2025-05-20 | Tooth Margaret | Director, Officer, CEO | Open Market Sale | -4,000 | 45.86 | -183,434.00 | -90,9% | |
| 2025-05-19 | MCGIBNEY BRENNA | Officer, Chief Administration Officer | Open Market Sale | -2,421 | 45.81 | -110,906.01 | -54,9% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.